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Abstract Interest in the proper neuropathological and
molecular characterization of bovine spongiform encepha-
lopathy (BSE) has increased since asymptomatic and atypi-
cal cases were detected in the cattle population by active
disease surveillance. In this respect we investigated a total
of 95 conWrmed BSE cases originating from diVerent active
and passive surveillance categories (clinical suspects, emer-
gency-slaughter, fallen stock and routinely slaughter) in
Switzerland for their neuropathological and molecular phe-
notype. We looked for measurable diVerences between
these categories in lesion proWle, severity of spongiform
change, degree of astrocytosis as well as immunohisto-
chemical and molecular patterns of the disease-associated
isoform of the prion protein (PrPd) in the caudal brainstem.
Our results indicate signiWcantly higher intensities of
spongiform change in clinically aVected compared to
asymptomatic BSE cases. Similar eVects were in trend
observed for the intensities of PrPd deposition and astrocy-
tosis, whereas the frequencies of morphological PrPd types
and the molecular patterns in Western immunoblot were
not diVerent. Importantly, none of the animals included
in this study revealed features of atypical BSE. Taken
together, this study suggests that both clinically aVected as
well as asymptomatic Swiss BSE cases in cattle share the
neuropathological and molecular phenotype of classical
BSE and that asymptomatic classical BSE cases are at a
pre-clinical stage of the disease rather than representing a
true sub-clinical form of BSE.
Keywords Bovine spongiform encephalopathy · Prion · 
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Introduction
The epidemic nature of bovine spongiform encephalopathy
(BSE) in the UK, its subsequent spread to most countries of
Europe and the discovery of its zoonotic character in 1996
resulted in the continuous monitoring for BSE worldwide.
Switzerland was the Wrst country to complement passive
disease surveillance by mandatory reporting of clinical sus-
pects (CS), with a comprehensive active BSE surveillance
program by targeting routinely slaughtered (“healthy”)
(RS) and emergency-slaughtered (ES) adult cattle as well
as fallen stock (FS) [10]. This led to the Wrst conWrmation
of BSE in cattle without any previous clinical BSE suspi-
cion [24, 27]. Since 2001, similar BSE monitoring and
epidemio-surveillance programmes were implemented in
European Union member states and consistently led to an
increase in detected BSE cases. As neurological signs were
not reported in many of the conWrmed cases, concerns were
raised that sub-clinical forms of the disease may exist [20],
viz. silent carriers as known from other important infectious
animal diseases [23, 30], that in contrast to animals in a pre-
clinical stage would not reveal clinical signs during their
normal live span.
More recently, atypical variants of BSE have been iden-
tiWed by active surveillance programmes Wrst in Italy [7],
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502 Acta Neuropathol (2007) 114:501–508France [3] and Japan [34], and later in a series of other
countries [1, 4]. All these cases showed an aberrant molec-
ular phenotype of the proteinase K resistant part of the
pathological prion protein (PrPres) in Western immunoblot
(WB) analysis and a noticeable old age when compared to
classical BSE aVected cattle. With the exception of one
case in a zebu [28], all such atypical BSE cases were identi-
Wed by active surveillance and therefore clinical features
were not reported or remained ambiguous [4], further sup-
porting the notion that sub-clinical BSE forms may indeed
exist.
The characterization of the phenotype of transmissible
spongiform encephalopathies (TSE) includes lesion proWles
in the central nervous system (CNS) [29], molecular typing
of PrPres by WB [21] and transmission studies to animal
models [5]. Recently, the neuroanatomical distribution and
morphological type of the disease-associated isoform of the
prion protein (PrPd) as determined by Immunohistochemis-
try (IHC) in the obex region of the caudal brainstem were
established as additional criteria to distinguish between
BSE phenotypes [8].
Since the Swiss BSE epidemic was monitored by both,
passive and active surveillance, we had the opportunity to
collect brain material from bovines with typical BSE neuro-
logical signs as well as conWrmed cases of BSE detected
from any of the active surveillance streams (ES, FS, RS).
Categories ES and FS include cases without BSE-associ-
ated neurological signs, and RS cattle did not have any clin-
ical history. All animals were diagnosed between 1999 and
2002 with an equal spread over time of the categories and
the presence of PrPd in the CNS was conWrmed by IHC on
obex sections. We looked for measurable neuropathological
diVerences in the caudal brainstem between animals of
these categories according to the lesion proWle, severity of
spongiform change, degree of astrocytosis as well as immu-
nohistochemical and molecular PrPd patterns. The purpose
of this study was to answer the question whether asymp-
tomatic BSE cases diVer in these phenotypic features from
clinical BSE cases, to assess whether they could be classi-
Wed as sub-clinical or rather pre-clinical BSE and if any of
those cases show patterns indicative of atypical BSE.
Materials and methods
Tissue samples
Between January 1999 and August 2002 a total of 148
domestic bovine BSE cases had been submitted to our labo-
ratory for conWrmatory diagnosis. Based on the availability
of tissues and a preliminary assessment of the tissue quality
in terms of autolysis, 95 brainstem samples were found to
be appropriate for a neuropathological assessment and were
included in the present study. Five non-BSE brainstems
served as negative control samples in order to conWrm the
speciWcity of the techniques and antibodies used. Samples
were grouped into four diVerent categories based on the
surveillance stream that they originated from (a) clinical
BSE suspected animals representing cows with neurologi-
cal signs suggestive of BSE, (b) ES cattle which were
removed from the population for health-related reasons and
were slaughtered sick, (c) FS which were found dead or
culled due to health or age related problems and having
their carcass subsequently disposed oV and (d) RS cattle,
which were considered to be slaughtered healthy (Table 1).
From all cases, the half brainstem was Wxed in 4% formal-
dehyde for 7–15 days, treated in 96% formic acid for 1 h
and embedded in paraYn for further routine histopathologi-
cal and immunohistochemical examination. The second
half was frozen and used for BSE screening tests and
molecular PrPres typing.
Immunohistochemistry
For IHC, 4-m sections of the obex were cut and immuno-
labelled for the presence of the PrPd and glial Wbrillary
acidic protein (GFAP). For PrPd detection, slides were sub-
jected to hydrated autoclaving at 121°C, 1 b, for 30 min in
distilled water, then treated with 98% formic acid (Merck)
for 5 min at room temperature and Wnally treated with 5 g/
ml proteinase K (Roche) for 15 min at 37°C. Endogenous
peroxidase activity was inhibited with 0.03% hydrogen per-
oxide (Merck) for 15 min, followed by washing in distilled
water. Then, slides were incubated overnight at 4°C either
with the rabbit-polyclonal antibody C15S [17] at dilution
of 1:800 in PBS or the rabbit-polyclonal anti-GFAP (Dako,
no pre-treatment, 1:600). After washing, sections were pro-
cessed with the Chemate™ Detection Kit Peroxidase/AEC
Rabbit/Mouse (Dako) following the instructions of the
Table 1 Numbers of examined animals and conWrmed BSE cattle
cases in the frame of active and passive surveillance in Switzerland
from 1999 to 2002
Surveillance category Numbers of animals
Examined ConWrmed 
BSE
Included in the
present study
Passive surveillance
Clinical suspect (CS) 451 59 45
Active surveillance
Emergency 
slaughter (ES)
24,327 28 18
Fallen stock (FS) 33,023 38 18
Regular slaughter (RS) 335,119 23 14
Total 392,920 148 95123
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haematoxylin before mounting (Glycergel, Dako).
Assessment of BSE-associated pathology
Spongiform change was semi-quantitively assessed in Wve
diVerent neuroanatomical areas in the obex region: the dor-
sal motor nucleus of the vagus nerve (DMNV), the solitary
tract nucleus (ST), the reticular formation (RF), the spinal
tract nucleus of the trigeminal nerve (STT) and the inferior
olives nuclei (ON). For practical purposes, the DMNV and
ST were grouped together and scored as single nucleus
(DMNV-ST). Two trained pathologists scored all slides
independently and blindly. First analyses showed that
scores did not diVer signiWcantly between the two investi-
gators (non-parametric test for paired observations). There-
fore, the scores assigned by one investigator were used for
further analysis. The lesion scoring was done from 0 to 5
following the criteria described in mouse models of scrapie
[15] rather than that adapted for cattle with BSE with
ranges from 0 to 4 following the criteria described previ-
ously for cattle with BSE from 0 to 4 [32]: 0, no vacuoles;
1, few vacuoles; 2, few vacuoles evenly scattered; 3, mod-
erate numbers of vacuoles; 4, many vacuoles with some
conXuence and 5, dense vacuolation with most of Weld
conXuent.
Disease-associated prion protein deposition was semi-
quantitively scored from 0, no PrPd to 5, severe PrPd depo-
sition in the same neuroanatomical structures as per the
lesion scores. Moreover, the presence of diVerent morpho-
logical PrPd types was determined in each of the examined
nuclei as Wne punctate granular, coarse granular, coalesc-
ing, glial (stellate), linear, perineuronal, intraneuronal or
intraglial.
Finally, GFAP-positive astrocytes were overall semi-
quantitively scored for obex sections: 1, mild; 2, moderate;
3, severe astrocytosis.
Western immunoblotting
Tissue samples of the caudal brainstem, in some cases of
the thalamus, were analysed in duplicate by WB follow-
ing the protocol of the commercial Prionics Check West-
ern Kit (Prionics) using the PrP speciWc monoclonal
antibodies (mAb) 6H4 (Prionics) and P4 (R-biopharm)
separately with the following modiWcations: ten well 12%
NuPage gels (Invitrogen) were used, the secondary anti-
body was a rabbit-anti-mouse-HRP-conjugate (Dako,
1:3,000) and the detection was done with the ECL plus kit
(Amersham Biosciences). For each gel the two outer lanes
were loaded with the precision® all-blue molecular mass
marker (Bio-Rad). For the molecular PrPres characteriza-
tion, photographic Wlms were scanned and the molecular
masses and relative intensities of the diglycosylated,
monoglycosylated and unglycosylated PrPres moieties
were measured for each sample using the Quantity-One
Software (Bio-Rad).
Statistical analyses
Lesion scores and PrPd scores were summarized using
medians and ranges, and visualized by box plots. For com-
parison of these scores as well as animal age between the
four surveillance streams, a Kruskal–Wallis ANOVA on
Ranks with post hoc Kruskal–Wallis multiple comparison
Z-test and Bonferroni correction for multiple comparison
was employed. Correlation between the lesion- and PrPd
scores as well as between diVerent anatomical regions were
assessed by the Spearman Rank correlation coeYcient
(rSp). All statistics were done with NCSS 2004
(www.ncss.com), and the alpha level for statistical signiW-
cance was set to 0.05.
Results
Spongiform lesions and PrPd deposition scores
Spongiform change was assessed in four diVerent neuroan-
atomical structures of the obex region (Fig. 1, lesion score).
For all animal categories the median of the lesion score was
highest either in the DMNV-ST or the STT and lowest in
the ON and RF. In CS animals the DMNV-ST and the STT
displayed the highest median of the lesion scores (3.0)
compared to the lowest median scores found in the RF
(1.0). For ES and FS but not for RS cattle, the STT revealed
lesion scores as high as for CS cattle (median 3.0). By con-
trast in the DMNV-ST and the ON spongiform lesions for
ES and FS tended to score lower compared to CS and rather
similar to RS animals. rSp of 0.47–0.50 indicated low
correlations of lesion scores between the structures under
investigation.
Regarding the intensities of PrPd deposition (Fig. 1, bot-
tom panel) the highest median scores were found in the
DMNV-ST of CS (3.0) and ES (3.0) animals. The median
PrPd scores of RS cases consistently scored lower com-
pared to those in CS animals, although not statistically
signiWcantly. Similar to the spongiform lesion scores,
PrPd scores in ES and FS animals were close to those of CS
animals in the STT, but in the ON resembled those of RS
animals. Analyses for the correlation of PrPd scores
between these structures revealed rSps ranging from 0.54 to
0.68, indicating a moderate correlation.
Overall, the correlation between PrPd deposition and
spongiform lesions in the respective nuclei was at best low
(rSps 0.3–0.51).123
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Eight diVerent PrPd types were identiWed in the obex
region by IHC using the rabbit-polyclonal anti-PrP anti-
body C15S. Noteworthy, none of the BSE cases included
in this study showed PrPd- immunopositive amyloidotic
plaques. In the DMNV-ST and the STT the Wne punctuate
and the coarse granular morphological PrPd types were
the most predominant (Fig. 2). In contrast to the rest of
the nuclei, the intraneuronal PrPd immunolabelling was
common in the ON whereas the stellate type completely
absent. Distinctively, the linear PrPd type predominated in
the RF.
When we compared the four animal categories the fre-
quency of PrPd deposition types in the each neuroanatomi-
cal structure was remarkably constant (Fig. 2). However, a
striking diVerence was that for the coalescing PrPd type the
frequencies overall dropped down from CS and ES to FS
animals and that this type was not detected in any of the
examined nuclei in RS cattle.
Astrocytosis
The median scores of the overall gliosis in the obex tissue
sections were 2.5, 2, 1.75 and 1.5 for CS, ES, FS and RS
animals, respectively. However, despite this clear trend,
diVerences in the scores between the four animal categories
were not statistically signiWcant due to rather broad varia-
tions (data not shown).
Molecular characterization
For a total of 71 BSE conWrmed cases appropriate frozen
CNS tissues were available. All cases showed a typical
three-band pattern consisting of two PrPres glycoforms of
approximately 22 and 27 kDa, and a unglycosylated moiety
of approximately 18 kDa in molecular mass by WB analy-
sis using mAb 6H4. The mean values of the molecular
Fig. 1 Spongiform change- and PrPd scoring for clinical suspect (CS),
emergency-slaughtered (ES), fallen stock (FS) and routinely slaugh-
tered (RS) BSE conWrmed cattle in four neuro-anatomical structures of
the caudal brainstem (obex level). Boxes represent the 25th, 50th (me-
dian: narrow section with bold line) and 75th percentile of the score
distribution within groups. Whiskers approximate the central 95%
of the data. Outliers are shown as dots. Statistical analysis resulted in
signiWcant diVerences (P < 0.05, indicated by asterisks) in the lesion
scores (spongiform change) in the dorsal motor nucleus of the vagus
nerve/solitary tract nucleus (DMNV-ST), the olivary nuclei (ON) and
the spinal tract nucleus of the trigeminal nerve (STT) but not in the
reticular formation (RF) between categories. By contrast, for PrPd
scoring although clear trends in median scores between categories are
identiWable, diVerences are not statistically signiWcant
Fig. 2 Frequencies of morphological PrPd deposition types in the four
brain stem nuclei under investigation (obex region) in BSE conWrmed
cattle. Note that each nucleus revealed a variety of types which diVer
in proportion and that multiple types per nucleus were frequently
observed. DiVerences were identiWed not only when nuclei were
compared but also between animals that derived from the four BSE
surveillance stream categories (see text)
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tially undistinguishable (Fig. 3a). Variations, especially of
the molecular mass of the unglycosylated peptide were only
to a minor extent within and between the four categories.
Also by visual side-by-side comparison no obvious diVer-
ences in the molecular masses of PrPres in individual sam-
ples were observed. Similarly, the proportions of the three
PrPres moieties did not reveal any obvious diVerences
between the categories although some variation was found.
Importantly, the diglycosylated moiety was predominant in
all samples under investigation (Fig. 3b) and exceeded 50%
of the total PrPres signal intensity in each case. None of the
samples, except for non-proteinase K treated controls
reacted with mAb P4.
Discussion
In this retrospective study we present a systematic neuro-
pathological and molecular comparison of BSE cases from
1999 to 2002 in Switzerland. The identiWcation of BSE
aVected cattle by passive surveillance relies on the report-
ing of animals with clinical signs indicative for BSE (CS),
followed by post mortem laboratory conWrmation of the
disease by one of the conWrmatory methods listed by the
OYce International de Epizooties [25]. Thus, CS BSE
cases can per se be regarded as clinically BSE aVected. For
active surveillance of FS cattle, direct neurological clinical
data are usually not collected. These animals were either in
an asymptomatic BSE state or died/were culled for other
reasons and clinical BSE signs remained unrecognised or
were not reported. The situation for RS and ES cattle is
diVerent in so far as according to Swiss regulations cattle
intended for slaughter undergo ante mortem inspection
complemented by BSE-speciWc clinical examination proce-
dures for those over 30 month of age [19]. RS cattle passed
this barrier and therefore are likely clinically healthy. How-
ever, for ES cattle BSE unrelated symptoms might have
masked speciWc neurological signs and consequently such
cases had not been recognized as CS. Taking these assump-
tions together we expect that animals identiWed by passive
surveillance were clinically BSE aVected and that the vast
majority of RS cases were indeed asymptomatic for BSE.
FS and ES cases were either of both and it is diYcult to
assess to which extend clinical cases were missed in these
categories. It was estimated that the odds ratio to detect
BSE in ES and FS animals was »50 compared to RS ani-
mals [10] and it is adequate to postulate, that a proportion
of them was clinically aVected, while others were healthy.
All CS, ES and FS BSE cases showed spongiform
lesions in the STT and, with the exception of one animal for
each category, also in the DMNV-ST. For the RS category
two animals lacked spongiform lesions in the STT but not
in the DMNV-ST. These Wndings are in accordance with
previous studies on lesion proWles in BSE done in the UK
[29, 31, 33], Switzerland [14, 17] and elsewhere [9, 26]. All
agreed on the identiWcation of those three obex nuclei as
primary target structures for routine histopathological BSE
diagnostics. Taken additionally into account that we found
a similar obex topography of PrPd types (Fig. 2) as that
found in Italian and British classical BSE cattle [8], our
data strengthen former studies on clinically BSE aVected
Swiss cattle that revealed a histopathological BSE pheno-
type similar to British BSE cases [17, 18] and extend this
conclusion to asymptomatic BSE cattle identiWed in frame
of active surveillance in Switzerland.
The highest lesion scores for spongiform change in all
studied nuclei corresponded to CS and the lowest to RS
animals. These diVerences were statistically signiWcant in
the STT and the ON. Likewise PrPd scores tended to be
higher in CS as compared to RS animals. Depending on
the nuclei, ES and FS BSE cases overall scored more or
less intermediate in both criteria. We also found the high-
est frequencies of coalescing PrPd in CS, while it was
absent in RS BSE cases. Moreover astrocytosis was in
trend increasing from RS over FS and ES to the CS category.
Fig. 3 Molecular typing of PrPres by Western immunoblotting.
Molecular masses (a) and relative proportions (b) of the mono- and
diglycosylated PrPres moieties in BSE conWrmed cattle. CS clinical
suspect (n = 33), ES emergency slaughter (n = 16), FS fallen stock
(n = 17), RS routine slaughter (n = 5)
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PrPd deposits as well as astrogliosis and PrPd aggregation
in the obex region are overall more severe in clinically
aVected as compared to asymptomatic BSE cases. While
PrPd deposition by itself does not imply clinical disease, it
is not inappropriate to speculate that due to the slow pro-
gression of the disease and the long incubation period
which characterizes TSE infections, these Wndings reXect a
progression of the disease. Together with the uniform his-
topathological and immunohistochemical phenotype this
implicates that asymptomatic cattle are rather in a preclini-
cal state and unlikely remain per se sub-clinical. If so, one
would expect that animals that displayed BSE clinical
signs were older than those belonging to the RS category,
and similarly that animals with the highest lesion scores
were the oldest because of a longer incubation period. The
median age at death was 64.5 months in CS, ES and FS
and 74.5 months in RS cattle. Although the age range was
rather wide (43–142 months, with Wve animals older than
100 month) we were not able to establish a statistical cor-
relation between the age of the animals, the clinical status
and the lesion severity (data not shown). This lack of cor-
relation may be due to rather small numbers of animals
especially in the RS category or other uncertainties that are
still related to the pathogenesis of BSE especially under
Weld conditions, like diVerences in time points of infec-
tion, individual susceptibilities, infectious doses or other
factors. A limitation of our study is the restriction to brain-
stem/obex tissues. DiVerences between cases and catego-
ries may have been much more obvious when other parts
of the brain, which may become involved at later stages in
the disease, were included in the assessment. However, we
were limited to the brainstem in terms of consistency,
because of sampling being limited to the caudal brainstem
in a large number of animals. Therefore, we agree that an
experimental BSE cattle model in which all those vari-
ables are under control and complete brain is available
would be required to provide additional and more conclu-
sive evidence for the absence or the putative phenotype of
sub-clinical BSE infections.
In one point our results disagree with those described by
Casalone et al. [8]. Unexpectedly and contrary to our
results, they found a greater intensity of PrPd immunolabel-
ling in the active surveillance animal population (consid-
ered as healthy) compared to that recorded in clinical cases.
They speculated that active surveillance may “select” for
animals that show a higher degree of PrPd deposition prior
to onset of clinical disease compared to others. A possible
explanation for such an eVect may be diVerences in the
diagnostic sensitivity of the respective screening tests com-
pared to that of the conWrmatory procedures. In case that a
screening tests applied in active surveillance is less sensi-
tive than the conWrmatory test, it may select for cases with
stronger, while the latter also identiWes cases with weaker
PrPd deposits when it is applied to CS animals. Indeed, to
our knowledge, none of the evaluation studies of BSE
screening tests carried out so far [11–13] included positive
samples derived from active surveillance schemes, but were
based on the examination of clinically BSE aVected ani-
mals exclusively. Thus, the performance of the screening
test on asymptomatic BSE cases especially also in compari-
son with established protocols for conWrmatory diagnosis is
still undetermined. Another factor that might contribute to
such a “selection” is the common diYculty to identify and
sample the appropriate target area in active surveillance
samples due to tissue autolysis (esp. for FS) or the inappro-
priate use of sampling devices thereby missing the target
nuclei in the brainstem whereas for instance in IHC these
structures can be identiWed visually. In addition, to our
experience the use of sampling syringes provided by some
screening tests which have been widely used since 2001 in
the European Union, clearly results in an increased risk of
missing the diagnostic target areas in the caudal brainstem
whereas the Prionics Check Western test [27], which was
used for the vast majority of active BSE surveillance in
Switzerland between 1999 and 2004, uses hemi-sections of
the obex region that appear to contain these structures more
likely. DiVerent sampling and screening test procedures for
active surveillance in Switzerland therefore possibly com-
pensate for such “selection” eVects.
Atypical BSE is currently classiWed as H-type (high) or
L-type (low) according to the apparent molecular mass of
the unglycosylated PrPres fragment when compared to
classical BSE by WB analysis using mAbs that bind to the
central part of PrPres, like 6H4 [21]. Such diVerences are in
the range of 1.4 kDa for H-type but very subtle or even
absent for the L-type [6, 21]. By contrast the latter reveals
a less intense band of the diglycosylated PrPres isoform
(<50% of the total PrPres) whereas in classical BSE it was
found to be more prominant (>50%) [21]. Additionally, in
H-type cases mAbs binding to the N-terminus (e.g. P4)
readily detect PrPres, which is not the case for classical and
L-type BSE. Of all cases investigated in the present study
by WB with mAbs 6H4 and P4 none revealed molecular
features of H-type or L-type BSE and no diVerences in the
molecular phenotype between the four categories were
identiWed. It must be emphasized that for 24 animals
appropriate frozen tissues were not available. Conse-
quently the molecular phenotype for these animals could
not be determined. For the remaining 71 cases it was
clearly that of classical BSE.
Little is known about the histopathological and immuno-
histochemical characteristics of atypical BSE. In two Italian
cases, Casalone et al. [7, 8] described the presence of PrPd
positive amyloidotic plaques mainly in the RF and the
nucleus of the STT of the brainstem as pathognomonic for123
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form encephalopathy (BASE). These animals revealed a
neuroanatomical PrPd distribution distinct from classical
BSE and involved mainly the more rostral parts of the brain
and to a lesser extent the caudal brainstem. By contrast
amyloidotic plaques have not yet been described in bovine
H-type BSE cases, but in the brain of mice after transmis-
sion of the H-type agent [2]. Recently we reported a minia-
ture zebu presenting an H-type molecular PrPres pattern
[28]. The type and distribution of the histopathological
lesions as well as the PrPd depositions in the brain were
undistinguishable from classical BSE in cattle. Whether
this also applies for H-type BSE in cattle still remains to be
determined. With the current knowledge and low incidence
it appears diYcult to discriminate H-type BSE cases on the
basis of the PrP deposition types from classical BSE. How-
ever, it is possible that suitable tests based on the same
principle as the epitope mapping IHC used for TSE strain
discrimination in small ruminants [16, 22] could be devel-
oped in the near future. None of the animals investigated
here, including the 24 cases that remained unclassiWed so
far, revealed plaque- like PrPd depositions indicative for
L-type BSE (or BASE).
In conclusion, the present retrospective study shows that
the neuropathological phenotype of the Swiss BSE cases
included in this study and the molecular phenotype of all
cases where appropriate tissue was available is that of clas-
sical BSE and remains remarkably constant irrespective of
the surveillance stream and therefore the clinical BSE sta-
tus. However, signiWcant diVerences in BSE related pathol-
ogy exist between clinical and asymptomatic BSE cases,
but are related to severity and spread of spongiform lesions
in brainstem nuclei and can be explained by the progressive
nature of the disease. Thus, these results suggest that
asymptomatic animals with conWrmed BSE were at a pre-
clinical stage of the disease rather than representing a true
sub-clinical form of BSE. Therefore, this study does not
support the notion that classical BSE would be maintained
as a clinically silent form of BSE in the cattle population.
None of the BSE animals under investigation showed fea-
tures of atypical BSE, but this study was limited in sample
size and if atypical BSE as often speculated represents a
sporadic TSE in bovine that mainly aVects older animals,
than its prevalence in a given population should be directly
proportional to the numbers of older animals tested.
Although the Swiss H-type zebu revealed clinical neurolog-
ical signs indicative for BSE, we do not know whether this
also applies for H- and L-type BSE cattle and consequently
they may not fall into the CS surveillance category, which
was highly represented, in the present study. Considering
these caveats, ongoing more extended work will clarify
whether and to which extend atypical BSE cases are part of
the Swiss BSE epidemic.
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